As of 2025-06-30, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is -1.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is 129.30 mil USD. BLUE's TTM EBITDA according to its financial statements is -116.20 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 13.6x | 13.2x |
| Forward P/E multiples | 20.7x - 28.0x | 25.4x |
| Fair Price | (253.70) - (169.67) | (237.32) |
| Upside | -5204.7% - -3513.8% | -4875.1% |
| Date | EV/EBITDA |
| 2025-05-30 | -1.11 |
| 2025-05-29 | -1.11 |
| 2025-05-28 | -1.11 |
| 2025-05-27 | -1.12 |
| 2025-05-23 | -1.11 |
| 2025-05-22 | -1.11 |
| 2025-05-21 | -1.11 |
| 2025-05-20 | -1.11 |
| 2025-05-19 | -1.11 |
| 2025-05-16 | -1.11 |
| 2025-05-15 | -1.11 |
| 2025-05-14 | -1.11 |
| 2025-05-13 | -0.97 |
| 2025-05-12 | -0.97 |
| 2025-05-09 | -0.99 |
| 2025-05-08 | -1.01 |
| 2025-05-07 | -1.00 |
| 2025-05-06 | -1.02 |
| 2025-05-05 | -1.03 |
| 2025-05-02 | -1.03 |
| 2025-05-01 | -1.04 |
| 2025-04-30 | -1.04 |
| 2025-04-29 | -1.04 |
| 2025-04-28 | -1.05 |
| 2025-04-25 | -1.04 |
| 2025-04-24 | -1.04 |
| 2025-04-23 | -1.04 |
| 2025-04-22 | -1.06 |
| 2025-04-21 | -1.02 |
| 2025-04-17 | -1.04 |
| 2025-04-16 | -1.04 |
| 2025-04-15 | -1.07 |
| 2025-04-14 | -1.10 |
| 2025-04-11 | -1.13 |
| 2025-04-10 | -1.09 |
| 2025-04-09 | -1.10 |
| 2025-04-08 | -1.10 |
| 2025-04-07 | -1.10 |
| 2025-04-04 | -1.11 |
| 2025-04-03 | -1.11 |
| 2025-04-02 | -1.12 |
| 2025-04-01 | -1.14 |
| 2025-03-31 | -1.11 |